Staak M, Moosmayer A
Arzneimittelforschung. 1978;28(7):1187-91.
Pharmacokinetic investigations concerning possible interactions of an orally administered single dosage of 20 mg dipotassium clorazepate and ethanol were conducted with 14 male subjects. Blood alcohol concentrations did not appear to be influenced by dipotassium clorazepate or its metabolites nordiazepam and oxazepam. The increase in oxazepam glucuronide excreted in the urine, however, was statistically significant. Nordiazepam concentration in the serum differed considerably between the group with ethanol administration and the control group. This metabolization pattern is apparently the result of the inhibitory effect of ethanol on hydroxylization processes during biotransformation of the metabolite nordiazepam.
对14名男性受试者进行了药代动力学研究,以探讨口服单剂量20mg氯氮䓬二钾与乙醇之间可能存在的相互作用。血液酒精浓度似乎不受氯氮䓬二钾及其代谢产物去甲西泮和奥沙西泮的影响。然而,尿液中排泄的奥沙西泮葡萄糖醛酸苷的增加具有统计学意义。乙醇给药组和对照组之间血清中去甲西泮的浓度差异很大。这种代谢模式显然是乙醇对代谢产物去甲西泮生物转化过程中羟基化过程的抑制作用的结果。